Haleon logo

HaleonNYSE: HLN

Profile

Sector:

Healthcare

Country:

United Kingdom

IPO:

25 July 2022

Next earnings report:

28 February 2025

Last dividends:

16 August 2024

Next dividends:

N/A
$44.58 B
-9%vs. 3y high
98%vs. sector
-8%vs. 3y high
54%vs. sector
-9%vs. 3y high
59%vs. sector
-9%vs. 3y high
48%vs. sector

Price

after hours | Fri, 01 Nov 2024 23:16:57 GMT
$9.86+$0.17(+1.75%)
$3.50 B$3.71 B
$3.50 B$382.29 M

Analysts recommendations

Institutional Ownership

HLN Latest News

Panadol maker Haleon takes hit from currency headwinds
proactiveinvestors.co.uk31 October 2024 Sentiment: POSITIVE

Currency fluctuations meant Haleon PLC (LSE:HLN, NYSE:HLN), the FTSE 100-listed Panadol and Sensodyne owner, saw year-on-year reported revenue by 0.6% to £2.78 billion in the third quarter. Stripping away the impact of the weaker US dollar, the consumer health giant's organic revenues increased by 6.1%.

Haleon reports marginal decline in third-quarter revenue
reuters.com31 October 2024 Sentiment: NEGATIVE

Haleon reported a marginal fall in its third-quarter revenue on Thursday, hurt by declines in its pain relief and digestive health segments.

Futura Medical in line for $5m milestone payment as Haleon's US Eroxon launch gets underway
proactiveinvestors.co.uk07 October 2024 Sentiment: POSITIVE

Futura Medical PLC (AIM:FUM, OTC:FAMDF) has secured a $5 million milestone payment following the US launch of its flagship product, Eroxon. The payment was triggered as Haleon, the company's distribution partner, began fulfilling online pre-orders and making fast-acting erectile dysfunction gel available in American retail stores.

Haleon's buy rating restated after Pfizer cuts down stake
proactiveinvestors.co.uk01 October 2024 Sentiment: POSITIVE

UBS has reiterated its buy rating on Haleon PLC (LSE:HLN, NYSE:HLN) shares after news that former parent company Pfizer Inc (NYSE:PFE, ETR:PFE) further pared down its stake in the FTSE 100-listed Sensodyne and Panadol maker. Haleon, which comprises the former consumer divisions of Pfizer and GSK PLC (LSE:GSK, NYSE:GSK), agreed on an off-market purchase of approximately £230 million worth of its own shares after Pfizer said t was cutting its stake by around £2.1 billion.

Haleon buys back some shares as Pfizer sells down stake
proactiveinvestors.co.uk01 October 2024 Sentiment: POSITIVE

Haleon PLC (LSE:HLN, NYSE:HLN) said it has agreed to buy £230 million of its own shares from former co-parent Pfizer Inc (NYSE:PFE, ETR:PFE), which offloaded almost a $3.3 billion stake in the Sensodyne maker.  The FTSE 100 consumer health group said made the purchase at a price of 308p per share.

Sensodyne maker Haleon to raise stake in China JV
reuters.com27 September 2024 Sentiment: POSITIVE

British consumer healthcare company Haleon said on Friday it has agreed to raise its stake in its Chinese joint venture by 33% for 4.47 billion yuan ($637.35 million), taking its ownership to 88%.

Haleon Selects PubMatic as Supply Optimisation Partner to Enable More Effective, Sustainable Media Buying
globenewswire.com16 September 2024 Sentiment: POSITIVE

The global healthcare brand gains increased transparency and control by getting closer to the sell-side of the ecosystem The global healthcare brand gains increased transparency and control by getting closer to the sell-side of the ecosystem

Haleon lays out pricing for £1bn bond offering
proactiveinvestors.co.uk12 September 2024 Sentiment: POSITIVE

Haleon PLC (LSE:HLN, NYSE:HLN) has unveiled pricing for a near-£1 billion bond offering set to be carried out by its subsidiary this month. Some €750 million (£633 million) worth of Euro medium-term notes to mature in 2028 will be sold with a price of 2.875%, the FTSE 100-listed health firm announced Thursday.

Haleon Announces the Launch of Eroxon®, The First and Only FDA Cleared OTC Gel for Erectile Dysfunction, Available for U.S. Preorder Without a Prescription
prnewswire.com03 September 2024 Sentiment: POSITIVE

Eroxon ® is Haleon's first offering in the sexual health space Clinical studies show Eroxon® is safe and effective in men with ED Eroxon® is available now for Amazon pre-order; available on shelves and online at most major retailers in October 2024 WARREN, N.J. , Sept. 3, 2024 /PRNewswire/ -- Eroxon® , the first-and-only FDA cleared gel available without a prescription for the treatment of erectile dysfunction (ED), is now available for pre-order in the United States through Amazon and will be available at most major retailers in October 2024.

Haleon, Reckitt, Wizz Air: Stocks lifting despite global sell-off
proactiveinvestors.co.uk05 August 2024 Sentiment: POSITIVE

While the FTSE 100 continues to suffer its worst session in recent times, dropping 2.5%, there are a handful of companies which have been able to buck the bearish trend.  Out of London's blue chips, only Haleon and Reckitt have been able to lift into the green, up by 0.1% and 0.4% respectively.

What type of business is Haleon?

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

What sector is Haleon in?

Haleon is in the Healthcare sector

What industry is Haleon in?

Haleon is in the Drug Manufacturers - Specialty & Generic industry

What country is Haleon from?

Haleon is headquartered in United Kingdom

When did Haleon go public?

Haleon initial public offering (IPO) was on 25 July 2022

What is Haleon website?

https://www.haleon.com

Is Haleon in the S&P 500?

No, Haleon is not included in the S&P 500 index

Is Haleon in the NASDAQ 100?

No, Haleon is not included in the NASDAQ 100 index

Is Haleon in the Dow Jones?

No, Haleon is not included in the Dow Jones index

When was Haleon the previous earnings report?

No data

When does Haleon earnings report?

The next expected earnings date for Haleon is 28 February 2025